Form 4: Myomo Inc. Chief Medical Officer Harry Kovelman Reports Stock Sale to Cover Taxes
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 121 shares of common stock on October 3, 2024, to cover income taxes due on vesting of restricted stock units.
Summary
- On October 3, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 121 shares of common stock.
- The sale was executed to cover income taxes due on the vesting of restricted stock units.
- The price per share was $3.86.
- Following the transaction, Kovelman directly owns 123,435 shares of Myomo, Inc.
- The sale was made pursuant to an irrevocable election made in conjunction with the original grant in November 2020.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock transaction, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a common occurrence for publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| November 2020 | Original grant of restricted stock units in conjunction with irrevocable election. |
| 10/02/2024 | Vesting of restricted stock units. |
| 10/03/2024 | Transaction date of stock sale. |
| 10/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.